Cargando…

Cox Models Survival Analysis Based on Breast Cancer Treatments

BACKGROUND: The aim of this study is to evaluate the association between different treatments and survival time of breast cancer patients using either standard Cox model or stratified Cox model. METHODS: The study was conducted on 15830 women diagnosed with breast cancer in British Columbia, Canada....

Descripción completa

Detalles Bibliográficos
Autores principales: Abadi, Alireza, Yavari, Parvin, Dehghani-Arani, Monireh, Alavi-Majd, Hamid, Ghasemi, Erfan, Amanpour, Farzaneh, Bajdik, Chris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Research Center, Shahid Beheshti University of Medical Sciences 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171826/
https://www.ncbi.nlm.nih.gov/pubmed/25250162
_version_ 1782335955379683328
author Abadi, Alireza
Yavari, Parvin
Dehghani-Arani, Monireh
Alavi-Majd, Hamid
Ghasemi, Erfan
Amanpour, Farzaneh
Bajdik, Chris
author_facet Abadi, Alireza
Yavari, Parvin
Dehghani-Arani, Monireh
Alavi-Majd, Hamid
Ghasemi, Erfan
Amanpour, Farzaneh
Bajdik, Chris
author_sort Abadi, Alireza
collection PubMed
description BACKGROUND: The aim of this study is to evaluate the association between different treatments and survival time of breast cancer patients using either standard Cox model or stratified Cox model. METHODS: The study was conducted on 15830 women diagnosed with breast cancer in British Columbia, Canada. They were divided into eight groups according to patients’ ages and stage of disease Either Cox’s PH model or stratified Cox model was fitted to each group according to the PH assumption and tested using Schoenfeld residuals. RESULTS: The data show that in the group of patients under age 50 years old and over age 50 with stage I cancer, the highest hazard was related to radiotherapy (HR= 3.15, CI: 1.85-5.35) and chemotherapy (HR= 3, CI: 2.29- 3.93) respectively. For both groups of patients with stage II cancer, the highest risk was related to radiotherapy (HR=3.02, CI: 2.26-4.03) (HR=2.16, CI:1.85-2.52). For both groups of patients with stage III cancer, the highest risk was for surgery (HR=0.49, CI: 0.33-0.73), (HR=0.45, CI: 0.36-0.57). For patients of age 50 years or less with stage IV cancer, none of the treatments were statistically significant. In group of patients over age 50 years old with stage IV cancer, the highest hazard was related to surgery (HR=0.64, CI: 0.53-0.78). CONCLUSION: The results of this study show that for patients with stage I and II breast cancer, radiotherapy and chemotherapy had the highest hazard; for patients with stage III and IV breast cancer, the highest hazard was associated with treatment surgery.
format Online
Article
Text
id pubmed-4171826
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Cancer Research Center, Shahid Beheshti University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-41718262014-09-23 Cox Models Survival Analysis Based on Breast Cancer Treatments Abadi, Alireza Yavari, Parvin Dehghani-Arani, Monireh Alavi-Majd, Hamid Ghasemi, Erfan Amanpour, Farzaneh Bajdik, Chris Iran J Cancer Prev Original Article BACKGROUND: The aim of this study is to evaluate the association between different treatments and survival time of breast cancer patients using either standard Cox model or stratified Cox model. METHODS: The study was conducted on 15830 women diagnosed with breast cancer in British Columbia, Canada. They were divided into eight groups according to patients’ ages and stage of disease Either Cox’s PH model or stratified Cox model was fitted to each group according to the PH assumption and tested using Schoenfeld residuals. RESULTS: The data show that in the group of patients under age 50 years old and over age 50 with stage I cancer, the highest hazard was related to radiotherapy (HR= 3.15, CI: 1.85-5.35) and chemotherapy (HR= 3, CI: 2.29- 3.93) respectively. For both groups of patients with stage II cancer, the highest risk was related to radiotherapy (HR=3.02, CI: 2.26-4.03) (HR=2.16, CI:1.85-2.52). For both groups of patients with stage III cancer, the highest risk was for surgery (HR=0.49, CI: 0.33-0.73), (HR=0.45, CI: 0.36-0.57). For patients of age 50 years or less with stage IV cancer, none of the treatments were statistically significant. In group of patients over age 50 years old with stage IV cancer, the highest hazard was related to surgery (HR=0.64, CI: 0.53-0.78). CONCLUSION: The results of this study show that for patients with stage I and II breast cancer, radiotherapy and chemotherapy had the highest hazard; for patients with stage III and IV breast cancer, the highest hazard was associated with treatment surgery. Cancer Research Center, Shahid Beheshti University of Medical Sciences 2014 /pmc/articles/PMC4171826/ /pubmed/25250162 Text en © 2014 Cancer Research Center, Shahid Beheshti University of Medical Sciences http://creativecommons.org/licenses/by-nc/3.0/ This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.
spellingShingle Original Article
Abadi, Alireza
Yavari, Parvin
Dehghani-Arani, Monireh
Alavi-Majd, Hamid
Ghasemi, Erfan
Amanpour, Farzaneh
Bajdik, Chris
Cox Models Survival Analysis Based on Breast Cancer Treatments
title Cox Models Survival Analysis Based on Breast Cancer Treatments
title_full Cox Models Survival Analysis Based on Breast Cancer Treatments
title_fullStr Cox Models Survival Analysis Based on Breast Cancer Treatments
title_full_unstemmed Cox Models Survival Analysis Based on Breast Cancer Treatments
title_short Cox Models Survival Analysis Based on Breast Cancer Treatments
title_sort cox models survival analysis based on breast cancer treatments
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171826/
https://www.ncbi.nlm.nih.gov/pubmed/25250162
work_keys_str_mv AT abadialireza coxmodelssurvivalanalysisbasedonbreastcancertreatments
AT yavariparvin coxmodelssurvivalanalysisbasedonbreastcancertreatments
AT dehghaniaranimonireh coxmodelssurvivalanalysisbasedonbreastcancertreatments
AT alavimajdhamid coxmodelssurvivalanalysisbasedonbreastcancertreatments
AT ghasemierfan coxmodelssurvivalanalysisbasedonbreastcancertreatments
AT amanpourfarzaneh coxmodelssurvivalanalysisbasedonbreastcancertreatments
AT bajdikchris coxmodelssurvivalanalysisbasedonbreastcancertreatments